UC files appeal to revive CRISPR patent interference

The University of California, along with the University of Vienna and Emmanuelle Charpentier,  yesterday filed its opening brief with the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., in support of its appeal of the U.S. Patent Trial and Appeal Board's (PTAB) decision in the CRISPR-Cas9 interference.